The company issued the "on-site governance standards" to be fully implemented from April 1
Release time:
2022-04-06
News from our newspaper "On-site Governance Standard" was jointly compiled and completed by cement, pharmaceutical, cable, health and international trade companies. After the group company passed the examination, it was issued on 3# April 23 and will be fully implemented from 4# August 1 .
Starting from2021 , the company has comprehensively carried out the "three-year action of on-site governance" in production enterprises, aiming to promote the overall progress of safe and civilized production and production technology. The formulation of on-site standards and the determination of work objectives and quality standards are the key to the implementation of the "three-year action for on-site governance" plan. As the company's subsidiaries are located in different industries, the actual conditions, management level and emphasis on on-site governance are also different, resulting in differences in the technical level and safety and environmental conditions of the production site of each unit. For this reason, starting from the second half of 2021 , led by the group company, each unit organized personnel to carry out standard design for production site management. after many times of summary, review and revision, the company finally formed the first "full coverage" standardized document on production site management in the company's history.
"Site Management Standard" has carried out a comprehensive standardized and standardized design of the production site, ranging from the planning of people flow and logistics routes, the appearance color of buildings, to the placement of tools and the unification of various signs, all of which make detailed regulations one by one with reference to the experience of advanced enterprises in the same industry. Each enterprise is not only the formulator of standards, but also the executor of standards. The process of formulating standards is also the process of setting benchmarks and finding gaps. Therefore, from the beginning of the development of standards, some enterprises have begun to rectify the shortcomings of on-site management. From4 February 1 , the "on-site governance standard" officially "landed", which will further push the "on-site governance three-year action" into depth.
In response to the implementation of the "On-site Governance Standards", the relevant person in charge said that the standards are the minimum requirements to be achieved in the process of pursuing on-site progress, and are also the basic criteria used by the company for on-site inspection and evaluation. All units must follow The standards that have been designed and formulated will carry out on-site governance and improvement without compromise. At the same time, the standard keeps pace with the times. Since it is the first time for the company to compile on-site governance standards, it is inevitable that there are areas with poor consideration and unreasonable design. In the process of specific implementation, each enterprise should combine the actual on-site management. Continuously refine, optimize, and rationalize it, and upgrade and revise the content of the standard every year to achieve continuous improvement, circular improvement, and unremitting pursuit of advanced and excellence. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page